Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

The Javelin IVL catheter "has the ability to transform the way that physicians are able to treat patients,” Shockwave CMO Dr. Nick West said.

Dr. SoHyun Boo, medical director for Neurointerventional Surgery in RNI's Department of Neuroradiology, explained the device and its use. The Broadway represents an advance on existing catheter ...

Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.

Aaron Gunches is scheduled to be the first person executed by Arizona since 2022. Here's what to know about his planned ...

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding ...

Applications are now being accepted for Future Docs, a leadership program of the Chattanooga-Hamilton County Medical Society ...

Medtech Perfuze has raised €22m. With the infusion, the company will release its catheters to select stroke centres in the US.

Santa Clara, California-based Shockwave designed Javelin with a single 120-pulse lithotripsy emitter at the distal tip of the ...

Greg Wolfe purchased a $200,000 Medtronic PulseSelect machine for Vancouver General Hospital, which the hospital has used for ...

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA ...